Carregant...

Glucocorticoid Receptor Status is a Principal Determinant of Variability in the Sensitivity of Non-Small Cell Lung Cancer Cells to Pemetrexed

INTRODUCTION: Pemetrexed is an S-phase targeted drug in front-line or maintenance therapy of advanced non-squamous non-small cell lung cancer (NSCLC) but methods are needed for predicting the drug response. Dexamethasone is typically administered the day before, the day of and the day after pemetrex...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Patki, Mugdha, Gadgeel, Shirish, Huang, Yanfang, McFall, Thomas, Shields, Anthony F., Matherly, Larry H., Bepler, Gerold, Ratnam, Manohar
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4075060/
https://ncbi.nlm.nih.gov/pubmed/24736075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000111
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!